Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942))

Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942)) Publisher Pubmed

Faraji A¹ ; Oghabi Bakhshaiesh T² ; Hasanvand Z¹ ; Motahari R¹ ; Nazeri E² ; Boshagh MA² ; Firoozpour L³ ; Mehrabi H⁴ ; Khalaj A¹ ; Esmaeili R² ; Foroumadi A^{1, 3}

Show Affiliations

1. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
2. Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
3. Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
4. Department of Chemistry, Vali-e-Asr University of Rafsanjan, Rafsanjan, 77176, Iran

Source: European Journal of Medicinal Chemistry Published:2021

Abstract

The authors regret that in the published version of the article data in Table 1 is not visible due to the overlapping structure of compound 1. Corrected version of Table 1 is given below. The authors would like to apologise for any inconvenience caused. © 2021 Elsevier Masson SAS

Style	Citing Format
MLA	Faraji A, et al.. "Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942))." European Journal of Medicinal Chemistry, vol. 214, no. , 2021, pp. -.
APA	Faraji A, Oghabi Bakhshaiesh T, Hasanvand Z, Motahari R, Nazeri E, Boshagh MA, Firoozpour L, Mehrabi H, Khalaj A, Esmaeili R, Foroumadi A (2021). Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942)). European Journal of Medicinal Chemistry, 214(), -.
Chicago	Faraji A, Oghabi Bakhshaiesh T, Hasanvand Z, Motahari R, Nazeri E, Boshagh MA, Firoozpour L, et al.. "Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942))." European Journal of Medicinal Chemistry 214, no. (2021): -.
Harvard	Faraji A et al. (2021) 'Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942))', European Journal of Medicinal Chemistry, 214(), pp. -.
Vancouver	Faraji A, Oghabi Bakhshaiesh T, Hasanvand Z, Motahari R, Nazeri E, Boshagh MA, et al.. Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942)). European Journal of Medicinal Chemistry. 2021;214():-.
BibTex	@article{ author = {Faraji A and Oghabi Bakhshaiesh T and Hasanvand Z and Motahari R and Nazeri E and Boshagh MA and Firoozpour L and Mehrabi H and Khalaj A and Esmaeili R and Foroumadi A}, title = {Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942))}, journal = {European Journal of Medicinal Chemistry}, volume = {214}, number = {}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Faraji A AU - Oghabi Bakhshaiesh T AU - Hasanvand Z AU - Motahari R AU - Nazeri E AU - Boshagh MA AU - Firoozpour L AU - Mehrabi H AU - Khalaj A AU - Esmaeili R AU - Foroumadi A TI - Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942)) JO - European Journal of Medicinal Chemistry VL - 214 IS - SP - EP - PY - 2021 ER -

Style

Citing Format

MLA

Faraji A, et al.. "Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942))." European Journal of Medicinal Chemistry, vol. 214, no. , 2021, pp. -.

APA

Faraji A, Oghabi Bakhshaiesh T, Hasanvand Z, Motahari R, Nazeri E, Boshagh MA, Firoozpour L, Mehrabi H, Khalaj A, Esmaeili R, Foroumadi A (2021). Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942)). European Journal of Medicinal Chemistry, 214(), -.

Chicago

Faraji A, Oghabi Bakhshaiesh T, Hasanvand Z, Motahari R, Nazeri E, Boshagh MA, Firoozpour L, et al.. "Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942))." European Journal of Medicinal Chemistry 214, no. (2021): -.

Harvard

Faraji A et al. (2021) 'Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942))', European Journal of Medicinal Chemistry, 214(), pp. -.

Vancouver

Faraji A, Oghabi Bakhshaiesh T, Hasanvand Z, Motahari R, Nazeri E, Boshagh MA, et al.. Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942)). European Journal of Medicinal Chemistry. 2021;214():-.

BibTex

@article{ author = {Faraji A and Oghabi Bakhshaiesh T and Hasanvand Z and Motahari R and Nazeri E and Boshagh MA and Firoozpour L and Mehrabi H and Khalaj A and Esmaeili R and Foroumadi A}, title = {Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942))}, journal = {European Journal of Medicinal Chemistry}, volume = {214}, number = {}, pages = {-}, year = {2021} }

RIS

TY - JOUR
AU - Faraji A
AU - Oghabi Bakhshaiesh T
AU - Hasanvand Z
AU - Motahari R
AU - Nazeri E
AU - Boshagh MA
AU - Firoozpour L
AU - Mehrabi H
AU - Khalaj A
AU - Esmaeili R
AU - Foroumadi A
TI - Corrigendum to “Design, Synthesis and Evaluation of Novel Thienopyrimidine-Based Agents Bearing Diaryl Urea Functionality As Potential Inhibitors of Angiogenesis” [Eur. J. Med. Chem 209 (2021) 112942] (European Journal of Medicinal Chemistry (2021) 209, (S0223523420309144), (10.1016/J.Ejmech.2020.112942))
JO - European Journal of Medicinal Chemistry
VL - 214
IS -
SP -
EP -
PY - 2021
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract